A Randomized, Double-blind, Multicenter, Phase2 Trial to Evaluate the Safety and Efficacy of YH1177 or YH1177-D Otic Soultion in Patients With Otitis Media and Otorrhea
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Dexamethasone/piperacillin/tazobactam (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Otitis media; Otorrhoea
- Focus Therapeutic Use
- Sponsors Yuhan
- 22 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 25 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2020.
- 25 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2020.